Skip to main navigation

Skip to Content

Investors & Media Contact Us LinkedIn Twitter

About Us
- Discover Karuna
- Leadership
Our Focus
- Schizophrenia
- Psychosis in Alzheimer’s Disease
Pipeline & Programs
Patient Resources
Culture & Careers

SEC Filing Details

Overview
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
Investor Resources
Media Kit

SEC Filing Details

Document Details

Form

Filing Date

Mar 20, 2023

Document Date

Mar 20, 2023

Form Description

Report of unscheduled material events or corporate event

Filing Group

Current Reports

Company

Karuna Therapeutics

Issuer

Karuna Therapeutics, Inc.

Filing Formats

iXBRL

View HTML

XBRL

XBRL Viewer

EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT

EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

XML - XBRL INSTANCE DOCUMENT

Print Page Email Page RSS Feeds Email Alerts

About Us
Our Focus
Pipeline & Programs
Patient Resources
Culture & Careers
Investors & Media
Contact Us

Connect with us on LinkedIn Twitter

Copyright 2023 Karuna Therapeutics™. All Rights Reserved. Privacy Policy. Terms of Use. Social Media Community Guidelines.

Top